Holistic LC strategies, from UHPLC to HPLC and back
Jun 18 2010 Read 3709 Times
Author: Adrian Clarke, John Nightingale, Partha Mukherjee and Patrik Petersson on behalf of Unassigned Independent Article
UHPLC has recently become a powerful tool in pharmaceutical analysis, specifically for method development, routine and rapid analysis. However, there are often limited numbers of UHPLC instruments available within internal and external customers and they do not always have access to this technology. This article gives an overview of the development and application of a holistic LC strategy to facilitate the implementation of UHPLC within a global Pharmaceutical Development function. An approach is being adopted that will enable the translation (geometric scaling) of chromatographic methods from “core” generic UHPLC methods with <2 μm columns to HPLC with ≥3 μm columns. There are requirements for UHPLC to HPLC transfer and practical issues to consider, specifically: instrument dwell volume differences, ensuring consistent selectivity across different particle sizes, frictional heating effects and pressure-induced retention effects. Finally the article demonstrates examples of UHPLC to HPLC translations and the application in AstraZeneca R&D projects.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles Fundamental Aspects - Separation of the 4 Enantiomers of the Fungicide Spiroxamine by LC-MS/MS - Optimising the Chiral Separation of the Pesticide Diniconazole...
View all digital editions
Sep 08 2020 Sheffield, UK
Sep 14 2020 Virtual Symposium
Sep 21 2020 Budapest, Hungary
Sep 27 2020 Saint-Malo, France
Sep 28 2020 Bethesda, MD, USA